Terran Biosciences and Blumentech S.L. announce the acquisition of a patent portfolio covering the groundbreaking discoveries of prominent psychedelics researcher Dr. Jordi Riba
NEW YORK, April 13, 2022 /PRNewswire/ — Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Blumentech S.L. (“Blumentech”) to acquire Blumentech’s full patent portfolio and accompanying data, which includes multiple groundbreaking discoveries by the late Dr. Jordi Riba Serrano, […]